WEREWOLF THERAPEUTICS
0.9900
14-May-25 16:45:00
15 minutes delayed
Stocks
-0.0300
-2.94%
Today's range
0.9601 - 1.0395
ISIN
N/A
Source
NASDAQ
-
Werewolf Therapeutics to Present at the SVB Leerink Global Healthcare Conference
08 Feb 2022 08:00:01 By Nasdaq GlobeNewswire
-
Werewolf Therapeutics to Present at the H.C. Wainwright Bioconnect Conference
05 Jan 2022 08:00:02 By Nasdaq GlobeNewswire
-
Werewolf Therapeutics Added to the Nasdaq Biotechnology Index
14 Dec 2021 16:01:00 By Nasdaq GlobeNewswire
-
01 Dec 2021 08:00:02 By Nasdaq GlobeNewswire
-
Werewolf Therapeutics Reports Third Quarter 2021 Financial Results and Business Update
10 Nov 2021 07:00:02 By Nasdaq GlobeNewswire
-
Werewolf Therapeutics to Present at Upcoming Conferences in November 2021
08 Nov 2021 08:03:15 By Nasdaq GlobeNewswire
-
Werewolf Therapeutics Appoints Meeta Chatterjee, Ph.D., to its Board of Directors
28 Oct 2021 16:01:00 By Nasdaq GlobeNewswire
-
27 Oct 2021 07:30:00 By Nasdaq GlobeNewswire
-
Werewolf Therapeutics to Present at Upcoming Next-Gen Cytokine Therapeutics Summit
14 Sep 2021 08:00:01 By Nasdaq GlobeNewswire
-
Werewolf Therapeutics to Present at H. C. Wainwright Global Investment Conference
08 Sep 2021 08:00:03 By Nasdaq GlobeNewswire
-
18 Aug 2021 07:30:00 By Nasdaq GlobeNewswire
-
Werewolf Therapeutics Reports Second Quarter 2021 Financial Results and Business Update
12 Aug 2021 07:00:01 By Nasdaq GlobeNewswire
-
Werewolf Therapeutics Announces Its Addition to the Russell 2000® Index
24 Jun 2021 07:00:00 By Nasdaq GlobeNewswire
-
Werewolf Therapeutics Appoints Chulani Karunatilake, Ph.D. as Chief Technology Officer
15 Jun 2021 07:00:01 By Nasdaq GlobeNewswire
-
Werewolf Therapeutics Reports First Quarter 2021 Financial Results
10 Jun 2021 07:00:00 By Nasdaq GlobeNewswire
-
Werewolf Therapeutics Appoints Mike Sherman to its Board of Directors
28 May 2021 07:00:00 By Nasdaq GlobeNewswire
-
Werewolf Therapeutics to Present at Jefferies Virtual Healthcare Conference 2021
27 May 2021 07:30:00 By Nasdaq GlobeNewswire